2025-08-01 - Analysis Report
Okay, here's the analysis of Teladoc Health Inc (TDOC), presented in a structured report format:

## Teladoc Health Inc (TDOC) Stock Analysis

**Ticker:** TDOC
**Company Description:** Teladoc Health Inc. is a telehealth company providing virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -70.34%
*   **VOO Cumulative Return:** 83.19%
*   **Absolute Divergence:** -165.3
*   **Divergence Range:** Max: 456.6, Min: -165.3
*   **Relative Divergence:** 0.0

**Analysis:** TDOC has significantly underperformed the S&P 500 over the analyzed period.  The current divergence is at the lower end of its historical range, suggesting substantial underperformance relative to its own past fluctuations compared to the market.

### 2. Alpha, Beta Analysis

| Year       |   CAGR |   MDD |   Alpha |   Beta |   Cap(B) |
|:-----------|-------:|------:|--------:|-------:|---------:|
| 2015-2017  |    3   |   3.3 |       0 |    0.5 |      6.2 |
| 2016-2018  |   28   |  58.8 |      33 |    0   |      8.8 |
| 2017-2019  |   98   |  58.8 |      76 |    0   |     14.8 |
| 2018-2020  |  181   |  63.8 |     154 |    0   |     35.3 |
| 2019-2021  |  -43   |  63.8 |     -92 |    0   |     16.2 |
| 2020-2022  | -195   |  81.3 |    -202 |   -0   |      4.2 |
| 2021-2023  | -330   |  81.3 |    -351 |   -0.8 |      3.8 |
| 2022-2024  |  -74   |  81.3 |    -101 |   -1   |      1.6 |
| 2023-2025  |  -23   |  75.4 |     -71 |   -0.4 |      1.3 |

**Analysis:**

*   **CAGR:**  The historical CAGR shows periods of significant growth followed by sharp declines. Recent years have experienced substantial negative growth.
*   **MDD (Maximum Drawdown):** The MDD is consistently high, indicating significant volatility and potential for large losses.
*   **Alpha:**  Alpha values are largely negative, reflecting underperformance relative to the market on a risk-adjusted basis.
*   **Beta:** Beta values close to zero, and recently negative, suggesting that the stock price is not correlated with the overall market performance(S&P500).
*   **Cap(B):** Market capitalization has generally declined over the more recent periods analyzed.

### 3. Recent Price Action

*   **Current Price:** 7.21
*   **Last Market Data:** {'price': 7.21, 'previousClose': 7.4, 'change': -2.57}
*   **5-Day Moving Average:** 7.708
*   **20-Day Moving Average:** 8.172
*   **60-Day Moving Average:** 7.6117

**Analysis:** The current price is below all three moving averages, indicating a short-term downtrend. The recent price decrease of -2.57% compared to the previous close confirms this downward momentum.

### 4. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3295 (Low Risk)
*   **RSI:** 27.89 (Oversold)
*   **PPO:** -1.91
*   **Hybrid Signal:** cash_69%_Sell 1.0% of holdings (14 shares - Caution - MRI:0.33) (Cash Ratio: 69% on 2025-07-23)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Short-term decrease)
*   **Expected Return:** -9793.2%

**Analysis:**

*   The MRI indicates a *Low Risk* environment, which is somewhat contradictory considering the other indicators.
*   The RSI is in oversold territory, suggesting a potential for a price rebound, though this could be a value trap.
*   The PPO is negative, indicating the short-term moving average is below the long-term moving average, confirming a downtrend.
*   The Hybrid Signal is bearish.
*   The extremely negative Expected Return should be viewed with extreme caution. It suggests significant long-term underperformance relative to the S&P 500 if investing at the current time.

### 5. Recent News & Significant Events

*   **[2025-07-30]:**  Major business developments, regulatory changes, or market events are impacting TDOC.
*   **[2025-07-28]:** Analysts are discussing TDOC's performance in the context of industry and global economic trends.
*   **[2025-07-29]:**  TDOC's stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-01]:**  Market experts highlight both risks and opportunities, advising investors to monitor news and company announcements.

**Analysis:** The news suggests a period of significant change and volatility for TDOC, requiring close monitoring of company-specific announcements and market reactions.

### 6. Recent Earnings Analysis

| 날짜       |    EPS | 매출     |
|:-----------|-------:|:---------|
| 2025-07-30 |   -0.19 | 0.63 B$ |
| 2025-05-01 |   -0.53 | 0.63 B$ |
| 2024-10-31 |   -0.19 | 0.64 B$ |
| 2024-08-01 |   -4.92 | 0.64 B$ |
| 2025-07-30 |   -4.92 | 0.64 B$ |

**Analysis:** TDOC has consistently reported negative EPS values. While revenue has remained relatively stable, the negative earnings raise concerns about profitability.

### 7. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin   |
|:-------------|:----------|:----------------|
| 2025-06-30   | $0.63B    | 69.85%          |
| 2025-03-31   | $0.63B    | 68.73%          |
| 2024-12-31   | $0.64B    | 70.50%          |
| 2024-09-30   | $0.64B    | 71.94%          |
| 2024-06-30   | $0.64B    | 70.73%          |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|:-------------|:----------|:---------|
| 2025-06-30   | $1.42B    | -2.30%   |
| 2025-03-31   | $1.43B    | -6.52%   |
| 2024-12-31   | $1.49B    | -3.25%   |
| 2024-09-30   | $1.51B    | -2.21%   |
| 2024-06-30   | $1.50B    | -55.77%  |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable, hovering around $0.63-0.64B per quarter.
*   **Profit Margin:** Profit margins are strong, consistently above 68%, which suggests good operational efficiency. However, this is not translating to positive net income due to other expenses.
*   **Equity:** Equity has seen a slight decline over the past year.
*   **ROE:** Return on Equity is consistently negative, indicating that the company is not generating profits from its equity investments. The significant drop in 2024-06-30 raises concerns.

### 8. Overall Assessment

TDOC presents a complex picture. While revenue and profit margins (before accounting for other costs) appear reasonably healthy, the company struggles with profitability, as evidenced by negative EPS and ROE.  The stock has significantly underperformed the market and shows a strong downtrend. Technical indicators suggest it's oversold, but this may not be a reliable buy signal given the overall negative outlook.

**Recommendation:**  Given the negative financial performance, significant underperformance compared to the S&P 500, and prevailing downtrend, a *SELL* or *AVOID* recommendation is warranted.  Investors should closely monitor company announcements and any signs of a turnaround in profitability before considering an investment. The news suggests volatility, requiring careful consideration of potential risks and opportunities.

**Disclaimer:** This analysis is based on the provided data and should not be considered financial advice. Consult with a qualified financial advisor before making any investment decisions.
